Randhawa Simrat
Dianthus Therapeutics, Inc. · CHIEF MEDICAL OFFICER
Randhawa Simrat is listed in filings as CHIEF MEDICAL OFFICER at Dianthus Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 2, 2026, including sale activity. Recent filings connect the profile to Dianthus Therapeutics, Inc. (DNTH). The current snapshot covers public activity from Feb 4, 2025 to Jun 2, 2026. Reported amounts are shown as $3.3M to $4.2M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $380k4.2k shares | SellJun 1, 2026 | $91.37 | $95.35 | |
| $2M16.9k shares | SellJun 1, 2026 | $90.72 | $95.35 | |
| $487k5.4k shares | SellJun 1, 2026 | $89.72 | $95.35 |